|
Volumn 236, Issue 5, 2002, Pages 694-696
|
Letter to the editor [1] (multiple letters)
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGY;
CANCER ADJUVANT THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
LETTER;
PANCREAS ADENOCARCINOMA;
PANCREATICODUODENECTOMY;
PATHOLOGY;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
STANDARDIZATION;
SURVIVAL RATE;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
MORTALITY;
NOTE;
PANCREAS RESECTION;
PANCREAS TUMOR;
ADENOCARCINOMA;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
PANCREATECTOMY;
PANCREATIC NEOPLASMS;
SURVIVAL RATE;
|
EID: 0036835591
PISSN: 00034932
EISSN: None
Source Type: Journal
DOI: 10.1097/00000658-200211000-00023 Document Type: Letter |
Times cited : (28)
|
References (0)
|